Close Menu

mergers & acquisitions

The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A.

ZeptoMetrix develops and manufactures quality control standards and verification panels used in infectious disease molecular diagnostic testing.

Hologic said the acquisition of Biotheranostics will give it a company that operates in markets that are adjacent and complementary to its own.

The company anticipates total revenues of $3.9 billion for 2020, including $1 billion from its COVID-19-related business.

Gene by Gene and its FamilyTreeDNA division offer a range of genetic testing services, including for ancestry, forensics, paternity, and COVID-19.

The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.

Hologic said that Biotheranostics' PCR-based gene expression tests have been validated in large studies in areas of oncology with high growth potential.

Despite the havoc wreaked by the COVID-19 pandemic on the economy, several companies in the index saw their shares rise by triple-digit percentages last year.

Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags.

Canadian Life Science distributes a range of consumables for chromatography including liquid and gas chromatography columns as well as sample prep products.

Pages

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.